Your position:m.limatoxi.com>>EN>>EN>>API Review>>Exports grew despite supply chain challenges & drop in demfor Covid-19-related treatments: Economic Survey>> article
Exports grew despite supply chain challenges & drop in demfor Covid-19-related treatments: Economic Survey
Editor:xuezhe Clicks:0Date:2023-2-1 11:24:56
Keyword:Covid-19
Healthoo Information:
Exports grew despite supply chain challenges & drop in demfor Covid-19-related treatments: Economic Survey
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
  • The battle between Pfizer Gilead over COVID-19 drugs will continue
  • In the first half of 2022, Chongqing exported about 880 million yuan o...
  • Pfizer to Increase Production Capacity of COVID-19 Oral Drugs, Invest ...
  • Anke Bio Afana Collaborate on mRNA Vaccines for Mutant Strains Such as...
  • Anke Bio Afana Collaborate on mRNA Vaccines for Mutant Strains Such as...
  • Japans First! The Recombinant Protein COVID-19 Vaccine Introduced by T...
  • The $100 billion COVID-19 drug market
  • 5 Chinese Pharmaceutical Companies Authorized to Produce Key Ingredien...
    		•
    Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map